1 – 13 of 13
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Health-related quality of life in patients with generalized pustular psoriasis–a Swedish register study
(
- Contribution to journal › Article
- 2023
-
Mark
Economic Burden of Palmoplantar Pustulosis in Sweden : A Population-based Register Study
(
- Contribution to journal › Article
-
Mark
Comorbidities in patients with generalized pustular psoriasis : a nationwide population-based register study
(
- Contribution to journal › Article
-
Mark
Comorbidities in palmoplantar pustulosis : a Swedish population-based register study
(
- Contribution to journal › Letter
-
Mark
Prolonged Sick Leave Before and After Diagnosis of Generalized Pustular Psoriasis : A Swedish Population-based Register Study
(
- Contribution to journal › Article
-
Mark
Mortality in generalized pustular psoriasis : A population-based national register study
(
- Contribution to journal › Article
- 2022
-
Mark
Prevalence and incidence of generalized pustular psoriasis in Sweden : a population-based register study*
(
- Contribution to journal › Article
- 2017
-
Mark
Regional Differences in the Prescription of Biologics for Psoriasis in Sweden : A Register-Based Study of 4168 Patients
(
- Contribution to journal › Article
- 2016
-
Mark
Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice.
2016) In BioDrugs(
- Contribution to journal › Article
- 2015
-
Mark
Real-World Outcome Analysis of Continuously and Intermittently Treated Patients with Moderate to Severe Psoriasis after Switching to a Biologic Agent.
(
- Contribution to journal › Article
-
Mark
Register-Based Evaluation of Relative Effectiveness of New Therapies: Biologics Versus Conventional Agents in Treatment of Psoriasis in Sweden.
(
- Contribution to journal › Article
-
Mark
Resource Use in Patients with Psoriasis After the Introduction of Biologics in Sweden
(
- Contribution to journal › Article
- 2012
-
Mark
Switch to Biological Agent in Psoriasis Significantly Improved Clinical and Patient-Reported Outcomes in Real-World Practice
(
- Contribution to journal › Article